Sign in

CIK 0001498382

  • Non-accelerated filer
  • Smaller reporting company

TuHURA Biosciences, Inc./NV

Sign in to watch
Ticker
HURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NV
Entity type
Operating
EIN
990360497
Phone
+1 813-875-6600
Business address
10500 UNIVERSITY CENTER DR., SUITE 110, TAMPA, FL, 33612
Former names
Kintara Therapeutics, Inc., DelMar Pharmaceuticals, Inc., Berry Only Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-08-01 Praill Anthony Scott Chief Financial Officer Grant or award +240,087 277,273
2022-08-01 Praill Anthony Scott Chief Financial Officer Grant or award · Option (right to buy) +720,260 720,260
2021-12-08 Praill Anthony Scott Chief Financial Officer Purchase +28,700 $0.68 $19K 37,186
2021-04-29 Praill Anthony Scott Chief Financial Officer Other acquisition +8 7,548
2021-04-29 Praill Anthony Scott Chief Financial Officer Conversion +938 8,486
2021-04-29 Praill Anthony Scott Chief Financial Officer Conversion · Series B Convertible Preferred Stock −3,750 0
2021-03-31 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,540
2020-12-31 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,518
2020-09-30 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,496
2020-09-15 Praill Anthony Scott Chief Financial Officer Grant or award · Options (Right to Buy) +606,557 606,557
2020-06-30 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,474
2020-06-26 Praill Anthony Scott Chief Financial Officer Grant or award · Option (Right to Buy) +57,170 108,366
2020-03-31 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,452
2019-12-31 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,430
2019-09-30 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,408
2019-09-05 Praill Anthony Scott Chief Financial Officer Grant or award · Options (Right to Buy) +57,170 57,170
2019-09-05 Praill Anthony Scott Chief Financial Officer Grant or award · Options (Right to Buy) +51,196 51,196
2019-06-28 Praill Anthony Scott Chief Financial Officer Other acquisition +22 7,386
2019-03-29 Praill Anthony Scott Chief Financial Officer Other acquisition +211 $0.49 $103 73,632
2018-12-31 Praill Anthony Scott Chief Financial Officer Other acquisition +211 $0.34 $72 73,421

Page 1 of 2 · 27 trades